Literature DB >> 20004113

The change of cytokines in tear and blood after different pterygium operation.

Jeong Kyu Lee1, Young Soo Song, Jun Seop Shin, Young Sam Kwon, Mi Sun Shin, Jae Chan Kim.   

Abstract

Pterygium is an invasion of altered ocular tissue into the cornea. Bone marrow-derived stem cells have been reported to be involved in wound healing under chemotactic factors after pterygium removal and pain may act as a trigger signal. We evaluated the change of systemic and local chemotactic factors that could affect the mobilization and migration of BMSCs to the wound bed after conventional bare sclera pterygium excision. We also applied temporary amniotic membrane patch after pterygium removal, and compared the changes of cytokines with those of conventional bare sclera excision group. Substance-P (SP), vascular endothelial growth factor (VEGF), and stem cell factor (SCF) were measured in plasma and tear using ELISA and migrating CD34(+) cells by flow cytometry. The results showed that post-operative pain was much reduced (p<0.05), and SP, VEGF and SCF kept consistently lower levels in plasma after temporary amniotic membrane application. Circulating CD34(+) cells increased slightly in the temporary amniotic membrane patch group compared with marked increase in the bare sclera group. Thus, the application of a temporary amniotic membrane after pterygium removal might be an effective therapeutic means by controlling pain and excessive infiltration of bone marrow-derived stem cells. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004113     DOI: 10.1016/j.cyto.2009.11.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  3 in total

1.  Changes in cytokines in tears after endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction.

Authors:  J K Lee; T H Kim
Journal:  Eye (Lond)       Date:  2014-02-28       Impact factor: 3.775

2.  Subconjunctival bevacizumab for primary pterygium excision; a randomized clinical trial.

Authors:  Mohammad-Reza Razeghinejad; Mohammad Banifatemi
Journal:  J Ophthalmic Vis Res       Date:  2014-01

Review 3.  The emerging role of fibrocytes in ocular disorders.

Authors:  Feng Zhang; Ke Liu; Han Zhao; Yan He
Journal:  Stem Cell Res Ther       Date:  2018-04-13       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.